| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $6.56B | +111.2% |
| R&D Expense | $1.47B | +10.8% |
| SG&A Expense | $1.30B | +24.9% |
| Operating Income | $2.31B | +1527.2% |
| Pre-tax Income | $2.94B | +3929.3% |
| Income Tax | $363.6M | +311.7% |
| Net Income | $2.58B | +2618.5% |
| EPS (Basic) | $10.42 | +2505.0% |
| EPS (Diluted) | $9.48 |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $8.54B | +66.2% |
| Accounts Receivable | $265.3M | +57.6% |
| Current Assets | $18.11B | -91.1% |
| Total Assets | $22.54B | -89.1% |
| Current Liabilities | $7.94B | -96.0% |
| Long-term Debt | $4.23B | +42.1% |
| Total Liabilities | $12.27B | -93.9% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $2.56B | +177.0% |
| Investing Cash Flow | -$282.4M | -5337.1% |
| Financing Cash Flow | $2.83B | +448.7% |
| +2462.2% |
| Stockholders' Equity |
| $10.28B |
| +63.6% |